Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques.

Norwich Medical School, University of East Anglia, Norwich, UK. Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. University of Bristol, Bristol, UK. Cardiothoracic Imaging Unit, Hospital San Juan de Dios, Ressalta, HT Medica, Cordoba, Spain. Norfolk and Norwich University Hospital, Norwich, UK. Cardiology Department, Radboudumc, Nijmegen, The Netherlands. Norwich Medical School, University of East Anglia, Norwich, UK. p.garg@sheffield.ac.uk. Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. p.garg@sheffield.ac.uk. Norfolk and Norwich University Hospital, Norwich, UK. p.garg@sheffield.ac.uk.

BMC medical imaging. 2021;(1):164
Full text from:

Abstract

The role of inflammation in cardiovascular pathophysiology has gained a lot of research interest in recent years. Cardiovascular Magnetic Resonance has been a powerful tool in the non-invasive assessment of inflammation in several conditions. More recently, Ultrasmall superparamagnetic particles of iron oxide have been successfully used to evaluate macrophage activity and subsequently inflammation on a cellular level. Current evidence from research studies provides encouraging data and confirms that this evolving method can potentially have a huge impact on clinical practice as it can be used in the diagnosis and management of very common conditions such as coronary artery disease, ischaemic and non-ischaemic cardiomyopathy, myocarditis and atherosclerosis. Another important emerging concept is that of myocardial energetics. With the use of phosphorus magnetic resonance spectroscopy, myocardial energetic compromise has been proved to be an important feature in the pathophysiological process of several conditions including diabetic cardiomyopathy, inherited cardiomyopathies, valvular heart disease and cardiac transplant rejection. This unique tool is therefore being utilized to assess metabolic alterations in a wide range of cardiovascular diseases. This review systematically examines these state-of-the-art methods in detail and provides an insight into the mechanisms of action and the clinical implications of their use.

Methodological quality

Publication Type : Review

Metadata